CAS RN: 67878-15-3
Methyl 9-broMononanoate
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250501
100mg / 250mg / 1g / 5g / 25g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 67878-15-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
67878-15-3 / methyl 9-bromononanoate
Standard CAS: 67878-15-3
Multi CAS: No
Basic Information
copy
CAS
67878-15-3 copy
Multi CAS
No copy
Molecular Formula
C10H19BRO2 copy
Molecular Weight
251.160000 copy
Exact Mass
250.056840 copy
InChI
InChI=1S/C10H19BrO2/c1-13-10(12)8-6-4-2-3-5-7-9-11/h2-9H2,1H3 copy
InChIKey
UEWKXXYDRZHKCR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Fraction Csp3
0.9 copy
Rotatable bonds
8 copy
H-bond acceptors
2 copy
Molar refractivity
58.13 copy
TPSA
26.3 copy
LogP / Solubility
WLOGP
3.29 copy
MLOGP
2.9 copy
XLogP3
3.5 copy
Consensus LogP
3.23 copy
Log S (ESOL)
-2.94 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.99 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.98 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.92 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy